Protalix BioTherapeutics OverviewProtalix BioTherapeutics Net Income
Profitability analysis for PLX.
Quarterly Net Income
$18.32M
↑ 606.13% YoY
As of Mar 2026
Annual Net Income (TTM)
$15.33M
↑ 292.32% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...